These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8272237)

  • 1. Again on HCV prevalence and the different types of testing sera.
    Lombardi M; Dattolo P
    Nephrol Dial Transplant; 1993; 8(10):1181. PubMed ID: 8272237
    [No Abstract]   [Full Text] [Related]  

  • 2. Further insights into hepatitis C.
    Colombo M
    Ital J Gastroenterol; 1991 Dec; 23(9):574-5. PubMed ID: 1662092
    [No Abstract]   [Full Text] [Related]  

  • 3. [The prevalence of anti-HCV antibodies in the sera from dialysis patients collected in 1980].
    Patti AM; Santi AL; Vescia N; Mastroeni I
    Ann Ig; 1994; 6(4-6):633-5. PubMed ID: 8611236
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies.
    Moreira R; Pinho JR; Fares J; Oba IT; Cardoso MR; Saraceni CP; Granato C
    Can J Microbiol; 2003 Aug; 49(8):503-7. PubMed ID: 14608385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
    Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
    Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A prevalence study on hepatitis C infection in 4,055 healthy children of Beijing].
    Chen M; Xia S
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 May; 33(3):158-9. PubMed ID: 11864475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus-RNA, immunoglobulin M anti-HCV and risk factors in haemodialysis patients.
    Dentico P; Sacco R; Buongiorno R; Volpe A; Ranieri C; Carbone M; Carabellese S
    Microbios; 1999; 99(392):55-62. PubMed ID: 10624011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HCV antibodies in hemodialyzed patients in Tunisia].
    Hmida S; Mojaat N; Chaouchi E; Mahjoub T; Khlass B; Abid S; Boukef K
    Pathol Biol (Paris); 1995 Sep; 43(7):581-3. PubMed ID: 8570261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C infection in dialysis patients in Israel.
    Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
    Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of prevalence of anti-hepatitis C virus antibodies in differing South American populations.
    Robinson JW; Rosas M; Guzman F; Patarroyo ME; Moreno A
    J Med Virol; 1996 Oct; 50(2):188-92. PubMed ID: 8915886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay.
    Fabrizi F; de Vecchi AF; Como G; Lunghi G; Martin P
    Aliment Pharmacol Ther; 2005 Apr; 21(7):861-9. PubMed ID: 15801921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran.
    Assarehzadegan MA; Shakerinejad G; Noroozkohnejad R; Amini A; Rahim Rezaee SA
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus infection in Samoa and American Samoa.
    Armstrong GL; Williams IT; Maga UA; Viali S; Kuhnert WL; McGarvey ST
    Am J Trop Med Hyg; 2006 Feb; 74(2):261-2. PubMed ID: 16474081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of antibody to hepatitis C virus in 177 drug addicts].
    Ye S
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Feb; 14(1):45-8. PubMed ID: 8389248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis.
    Taglione E; Vatteroni ML; Martini P; Galluzzo E; Lombardini F; Delle Sedie A; Bendinelli M; Pasero G; Bencivelli W; Riente L
    J Rheumatol; 1999 Feb; 26(2):370-2. PubMed ID: 9972971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C prevalence studied by polymerase chain reaction and serological methods in haemodialysis patients in Mazandaran, Iran.
    Makhlough A; Jamshidi M; Mahdavi MR
    Singapore Med J; 2008 Nov; 49(11):921-3. PubMed ID: 19037560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association between hepatitis C and B-cell lymphoma.
    Collier JD; Zanke B; Moore M; Kessler G; Krajden M; Shepherd F; Heathcote J
    Hepatology; 1999 Apr; 29(4):1259-61. PubMed ID: 10094973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk.
    Daw MA; Elkaber MA; Drah AM; Werfalli MM; Mihat AA; Siala IM
    Saudi Med J; 2002 Nov; 23(11):1356-60. PubMed ID: 12506296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotyping of hepatitis C virus in hemodialysis patients: comparison with a standardized genotyping assay.
    Elsawy EM; Sobh MA; El-Chenawi FA; Hassan IM; Shehab El-Din AB; Ghoneim MA
    Diagn Microbiol Infect Dis; 2005 Feb; 51(2):91-4. PubMed ID: 15698713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.